CEOs respect importance of reputation

Share this article:
Healthcare CEOs are concerned about corporate reputation, according to a survey by FischerHealth, Porter Novelli Consulting and PRSA Health Academy.

Nearly two-thirds of the 30 CEOs surveyed said reputation was “critical” or “very important” to their organization's success, and similar numbers said a positive shift in reputation “significantly” or “dramatically” affects their bottom line.

A large majority (86%) said negative events would adversely impact their bottom line.

All rated their firm's reputation as “excellent” to “good” with key external audiences, including consumers, regulators, legislators and employees, though less than half (47%) rated their reputation with news media as “very good.”

However, more than one-third (39%) had not measured their reputation. Three-quarters of respondents said they were “satisfied” or “very satisfied” with their staff's ability to understand and deliver on reputation-management objectives.

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in News

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.